Source: Pharmaceutical Benefits Scheme (AU) Revision Year: 2022 Publisher: Viatris Pty Ltd, Level 1, 30 The Bond, 30-34 Hickson Road, Millers Point NSW 2000, www.viatris.com.au, Phone: 1800 274 276
MESASAL Mesalazine enteric-coated tablets.
| Pharmaceutical Form |
|---|
|
MESASAL 250 mg enteric-coated tablets are round, biconvex and tan coloured. |
Each enteric-coated tablet contains 250 mg of mesalazine as the active ingredient.
Excipients of known effect: contains 23.9 mg elemental sodium per 250 mg tablet.
For the full list of excipients, see Section 6.1 LIST OF EXCIPIENTS.
Chemical name: 5-amino-2-hydroxybenzoic acid
Molecular weight: 153.1
CAS Number: 89-57-6
| Active Ingredient | Description | |
|---|---|---|
| Mesalazine |
Mesalazine is an aminosalicylate. The mechanism of action of mesalazine is not fully understood, but appears to have a topical anti-inflammatory effect on the colonic epithelial cells. Mucosal production of arachidonic acid metabolites, both through the cyclooxygenase and lipoxygenase pathways, is increased in patients with chronic inflammatory bowel disease, and it is possible that mesalazine diminishes inflammation by blocking cyclooxygenase and inhibiting prostaglandin production in the colon. |
| List of Excipients |
|---|
|
The enteric-coated tablets also contain: calcium stearate, colloidal anhydrous silica, glycine, iron oxide red, iron oxide yellow, macrogol 6000, methacrylic acid copolymer, microcrystalline cellulose, povidone, purified talc, sodium carbonate, titanium dioxide and triethyl citrate. |
Container type: blister pack (PVC/PVDC/Al).
Pack sizes: 100
Some strengths, pack sizes and/or pack types may not be marketed.
AUST R 289132 – MESASAL mesalazine 250mg enteric-coated tablet blister pack.
Viatris Pty Ltd, Level 1, 30 The Bond, 30-34 Hickson Road, Millers Point NSW 2000, www.viatris.com.au, Phone: 1800 274 276
250 mg: 16/08/2017
| Drug | Countries | |
|---|---|---|
| MESASAL | Australia, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
